Pharma Mar Statistics
Total Valuation
Pharma Mar has a market cap or net worth of EUR 712.78 million. The enterprise value is 617.02 million.
Market Cap | 712.78M |
Enterprise Value | 617.02M |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
Earnings Date | Oct 25, 2024 |
Ex-Dividend Date | Jun 12, 2024 |
Share Statistics
Pharma Mar has 17.54 million shares outstanding. The number of shares has decreased by -4.79% in one year.
Shares Outstanding | 17.54M |
Shares Change (YoY) | -4.79% |
Shares Change (QoQ) | +0.68% |
Owned by Insiders (%) | 11.87% |
Owned by Institutions (%) | 7.48% |
Float | 13.61M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 28.82 |
PS Ratio | 4.49 |
PB Ratio | 3.93 |
P/FCF Ratio | n/a |
PEG Ratio | 0.27 |
Enterprise Valuation
EV / Earnings | -350.38 |
EV / Sales | 3.89 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -20.76 |
Financial Position
The company has a current ratio of 2.55, with a Debt / Equity ratio of 21.71.
Current Ratio | 2.55 |
Quick Ratio | 1.88 |
Debt / Equity | 21.71 |
Debt / EBITDA | n/a |
Debt / FCF | -1.32 |
Interest Coverage | -4.15 |
Financial Efficiency
Return on equity (ROE) is -0.90% and return on invested capital (ROIC) is -2.42%.
Return on Equity (ROE) | -0.90% |
Return on Assets (ROA) | -1.70% |
Return on Capital (ROIC) | -2.42% |
Revenue Per Employee | 311,988 |
Profits Per Employee | -3,460 |
Employee Count | 509 |
Asset Turnover | 0.47 |
Inventory Turnover | 0.25 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.35% in the last 52 weeks. The beta is 0.20, so Pharma Mar's price volatility has been lower than the market average.
Beta (5Y) | 0.20 |
52-Week Price Change | +14.35% |
50-Day Moving Average | 37.79 |
200-Day Moving Average | 35.69 |
Relative Strength Index (RSI) | 57.33 |
Average Volume (20 Days) | 33,681 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pharma Mar had revenue of EUR 158.80 million and -1.76 million in losses. Loss per share was -0.10.
Revenue | 158.80M |
Gross Profit | 148.35M |
Operating Income | -9.21M |
Pretax Income | -6.35M |
Net Income | -1.76M |
EBITDA | -6.20M |
EBIT | -9.21M |
Loss Per Share | -0.10 |
Balance Sheet
The company has 135.15 million in cash and 39.38 million in debt, giving a net cash position of 95.76 million or 5.46 per share.
Cash & Cash Equivalents | 135.15M |
Total Debt | 39.38M |
Net Cash | 95.76M |
Net Cash Per Share | 5.46 |
Equity (Book Value) | 181.38M |
Book Value Per Share | 10.34 |
Working Capital | 136.24M |
Cash Flow
In the last 12 months, operating cash flow was -9.58 million and capital expenditures -20.15 million, giving a free cash flow of -29.72 million.
Operating Cash Flow | -9.58M |
Capital Expenditures | -20.15M |
Free Cash Flow | -29.72M |
FCF Per Share | -1.69 |
Margins
Gross margin is 93.42%, with operating and profit margins of -5.80% and -1.11%.
Gross Margin | 93.42% |
Operating Margin | -5.80% |
Pretax Margin | -4.00% |
Profit Margin | -1.11% |
EBITDA Margin | -3.90% |
EBIT Margin | -5.80% |
FCF Margin | -18.72% |
Dividends & Yields
This stock pays an annual dividend of 0.65, which amounts to a dividend yield of 1.60%.
Dividend Per Share | 0.65 |
Dividend Yield | 1.60% |
Dividend Growth (YoY) | -38.27% |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 4.79% |
Shareholder Yield | 6.39% |
Earnings Yield | -0.26% |
FCF Yield | -4.17% |
Stock Splits
The last stock split was on July 22, 2020. It was a reverse split with a ratio of 0.0833333333.
Last Split Date | Jul 22, 2020 |
Split Type | Reverse |
Split Ratio | 0.0833333333 |